APA (7th ed.) Citation

FR, L., EH, B., KC, B., EK, C., LM, J., L, L., . . . L, P. (2024). Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British journal of haematology, 205(3), 1055. https://doi.org/10.1111/bjh.19679

Chicago Style (17th ed.) Citation

FR, LeBlanc, et al. "Clinical Outcomes of Hypomethylating Agents and Venetoclax in Newly Diagnosed Unfit and Relapsed/refractory Paediatric, Adolescent and Young Adult Acute Myeloid Leukaemia Patients." British Journal of Haematology 205, no. 3 (2024): 1055. https://doi.org/10.1111/bjh.19679.

MLA (9th ed.) Citation

FR, LeBlanc, et al. "Clinical Outcomes of Hypomethylating Agents and Venetoclax in Newly Diagnosed Unfit and Relapsed/refractory Paediatric, Adolescent and Young Adult Acute Myeloid Leukaemia Patients." British Journal of Haematology, vol. 205, no. 3, 2024, p. 1055, https://doi.org/10.1111/bjh.19679.